Kymera Therapeutics raises $250.8M in public offering to advance its innovative degrader medicines for immunological diseases.

The approval enables Trinity to transition upstream production from in-house operations to an outsourced model.

Pathway Triangle's King Street Properties confirmed that it has leased manufacturing space in Morrisville. What to know.

View the latest Trinity Biotech PLC ADR (TRIB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Now, just 24 games into his Trinity career, he’s led the program into uncharted territory. Before this season, the Shamrocks had never made the PIAA semifinals, and never made a PIAA final.

A biotechnology company based in Westchester, N.Y., Regeneron pledged to work with an independent, court-appointed customer-privacy ombudsman to protect clients — a requirement of all bidders in ...

Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront and $50 million in contingent payments, marking its entry into the global ...

Now, let’s check out the public biotech fundraising rounds that occurred in May 2025, breaking them down by value and therapeutic subsector. Public biotech funding by value. May 2025 saw Taysha Gene ...

Legend Biotech’s expectations could be affected by, among other things, uncertainties involved in the development of new pharmaceutical products; unexpected clinical trial results, including as a ...

Trinity Health Of New England has announced the closure of its women’s health services in Agawam, redirecting patients to their Chicopee or Springfield locations.

Before she became co-CEO of promising biotech firm Summit Therapeutics, Maky Zanganeh was a dentist, worked in robotic surgery, launched a blockbuster cancer drug and survived breast cancer.